Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does aurobindo's clonazepam production affect its anxiety reducing abilities?Lipitor check ups did lightheadedness occur?Can mmr vaccine interactions cause cosentyx side effects?Can you name companies supplying clonazepam's raw materials to aurobindo?Does a patient's weight affect cosentyx dosage?
See the DrugPatentWatch profile for spravato
Yes. Spravato (esketamine) is used to treat certain types of depression, specifically treatment-resistant depression and depressive episodes in adults with major depressive disorder who also have acute suicidal ideation or behavior. [1]
Spravato is indicated for: - Treatment-resistant depression in adults [1] - Major depressive disorder with acute suicidal ideation or behavior in adults [1]
Spravato is typically used in combination with an oral antidepressant for the approved depression indications. [1]
Spravato is not described as a general antidepressant for all types of depression. Its approved use is limited to the specific adult depression groups above (treatment-resistant depression, and major depressive disorder with acute suicidal ideation or behavior). [1]
Spravato is administered under healthcare supervision with monitoring, which is part of how the treatment is delivered for its approved depression indications. [1]
Other Questions About Spravato :